• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

chronic kidney disease (CKD)

Hypertension.
Posted inCardiology, Clinical Trials, In the Pipeline

Hypertension Treatment With One Shot Every Six Months

by Julia Mardi and Timur Burkhanayev April 27, 2024May 8, 2024

Zilebesiran and tonlamarsen are advanced and convenient ways to treat high blood pressure.

heart
Posted inCardiology, Pharma & Biotech

Cardior Pharmaceuticals: Advanced Treatment for Heart Failure

by Mark Gubar and Timur Burkhanayev April 5, 2024April 5, 2024

RNA therapy reverses pathological cardiac remodeling, improving heart function and prolonging life.

heart
Posted inCardiology, Clinical Trials, Metabolism

Baxdrostat: New Treatment for Resistant Hypertension

by Tanya von Reuss November 29, 2022April 5, 2024

A selective aldosterone synthase inhibitor for significantly lowering blood pressure.

Posted inMetabolism, New Drugs, Regulatory

Twymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus

by Nik Resovski and Timur Burkhanayev February 17, 2022September 8, 2022

Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.

Posted inMetabolism, New Drugs, Regulatory

Kerendia: New Drug for Diabetic Kidney Disease

by Mark Gubar February 16, 2022September 8, 2022

Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.

BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×